Learning Outcomes
By the end of this section, you should be able to:
- 40.4.1 Identify the characteristics of drugs used to treat miscellaneous dermatologic disorders and burns.
- 40.4.2 Explain the indications, actions, adverse reactions, and interactions of drugs used to treat miscellaneous dermatologic disorders and burns.
- 40.4.3 Describe nursing implications of drugs used to treat miscellaneous dermatologic disorders and burns.
- 40.4.4 Explain the client education related to drugs used to treat miscellaneous dermatologic disorders and burns.
In addition to acne and psoriasis, there are other common skin conditions for which clients may receive treatment. In this chapter they are divided into miscellaneous dermatologic conditions and burns.
Miscellaneous Dermatologic Disorders
This section focuses on the most common dermatological disorders not yet discussed, including cutaneous warts, atopic dermatitis (eczema), contact dermatitis, impetigo, and rosacea.
Cutaneous Warts
Cutaneous warts are a form of localized viral infection, resulting in the familiar raised lesions known as warts (Figure 40.5). Current therapies in the treatment of warts include medications that chemically burn these lesions, thus eliminating them. Cantharidin is one such drug. As a vesicant, cantharidin causes local tissue necrosis on those surfaces to which it is applied. This necrosis will eventually result in the sloughing of the wart and elimination of the virus.
Atopic Dermatitis (Eczema)
Atopic dermatitis (eczema) is another skin condition that requires pharmacological treatment. Unlike conditions characterized solely by local irritation, atopic dermatitis is a systemic disease that has genetic predispositions, involves the immune system, and also has environmental influences. This condition has also been linked to other disorders, including asthma and hay fever (National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2022). The etiology is not clearly understood, but treatment involves using oral and topical medications to relieve the characteristic lesions of atopic dermatitis (Figure 40.6). Hydrocortisone and pimecrolimus are often used topically to treat atopic dermatitis.
Contact Dermatitis
Contact dermatitis is an acute inflammation caused by aggravating factors that results in swollen, red, itchy lesions (Figure 40.7). Substances that may cause contact dermatitis include, but are not limited to, soaps, cosmetics, jewelry, and poison ivy/oak. Treatment focuses on decreasing inflammation and providing comfort and decreased pain and itching. Hydrocortisone, when applied to areas of contact dermatitis, acts to decrease inflammation, relieving the red, warm, edematous symptoms. In addition to hydrocortisone or other corticosteroid ointments, calamine lotion also may be used to reduce itching and promote healing. This solution is made by combining zinc oxide and ferric oxide, which, when applied to the skin, soothes the affected area and reduces itching and burning at the site.
Impetigo
Impetigo is a cutaneous bacterial infection that occurs on the upper surface of the skin (Figure 40.8). Typically, impetigo is seen in infants and children, although it may occasionally be seen in adults. The causative organisms are most often Staphylococcus aureus and Streptococcus pyogenes bacteria. Treatment encompasses application of mupirocin, a topical antibacterial. Retapamulin, another topical anti-infective used in impetigo, selectively inhibits protein synthesis to stop bacterial growth. Topical treatment with these agents usually clears impetigo, but if impetigo persists and is severe, oral antibiotics may be needed.
Rosacea
Rosacea is a skin condition that develops from an inflammatory process, causing redness, swelling, prominent small vessels, and papular lesions on the face (Figure 40.9). Metronidazole, an antifungal, is used in the treatment of rosacea to reduce redness and inflammatory lesions. Nurses should note that when absorbed systemically, metronidazole interacts negatively with many other medicines. When alcoholic beverages are mixed with metronidazole, a life-threatening disulfiram-like reaction may occur, resulting in palpitations, diaphoresis, flushing, nausea, and tachycardia (Stokes & Abdijadid, 2019). Sodium sulfacetamide, another treatment for rosacea, is antibacterial in function and is used to cleanse the skin and eliminate bacteria. Clients with sulfa allergies should not use sodium sulfacetamide.
Table 40.11 lists common miscellaneous dermatologic drugs and typical routes and dosing for adult and pediatric clients.
Drug | Routes and Dosage Ranges |
---|---|
Hydrocortisone (Cortef) |
Adults and children >2 years: Apply 1% cream topically to affected area 3 times daily. |
Methylprednisolone (Medrol) |
Adults: 4–48 mg/day orally, depending on the specific disease entity being treated. |
Calamine lotion (Calananz) |
Adults and children >2 years: Apply to area as needed, let dry. |
Retapamulin (Altabax) |
Adults: Apply a thin layer to the affected area (not to exceed 100 cm2) twice daily for 5 days. Children ≥9 months: Apply a thin layer on areas not to exceed 2% total body surface area twice daily for 5 days. |
Mupirocin (Bactroban) |
Adults and children >2 months: Apply ointment (2%) to area 2–3 times daily. |
Metronidazole (Flagyl) |
Adults: Apply gel (0.75%) topically and rub in a thin film twice daily, morning and evening. Children: Safety and effectiveness in pediatric clients have not been established. |
Sodium sulfacetamide (Sumaxin, Cetamide) |
Adults: Wash affected areas with 10% gel twice daily (morning and evening) or as directed by your physician. Children: Safety and effectiveness in children under 12 years has not been established. |
Pimecrolimus (Elidel) |
Adults and children >2 years: Apply a thin layer of 1% cream to affected areas twice daily. |
Cantharidin (Yanth) |
Adults and children >2 years: Apply topically to wart surface only; repeat every 3 weeks as needed. |
Safety Alert
Topical Steroids
When using topical steroids, the application sites should not be covered with an occlusive dressing. Breathable gauze dressings may be used. Topical corticosteroids are meant to exert a local effect; however, when these medications are covered with an occlusive dressing, systemic absorption may occur, leading to systemic side effects of the drug.
Adverse Effects and Contraindications
Adverse effects associated with topical medications for skin disorders include hypersensitivities. This is especially associated with mupirocin. Localized irritation, redness, and peeling may be noted with these medications as well. When covered with occlusive dressings, clients may experience systemic absorption, resulting in the likelihood of systemic effects. For this reason, occlusive dressings are contraindicated.
Steroid compounds are contraindicated in fungal infections. Long-term use of pimecrolimus, a calcineurin inhibitor, has been associated with the development of lymphomas. For this reason, long-term use is contraindicated.
Table 40.12 is a drug prototype table for common dermatologic medications featuring mupirocin. It lists drug class, mechanism of action, adult and pediatric dosage, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.
Drug Class Topical antibiotic Mechanism of Action Bactericidal; binds RNA transcription |
Drug Dosing Adults and children >2 months: Apply ointment (2%) to area 2–3 times daily. |
Indications Impetigo Therapeutic Effects Eradication of impetigo lesions |
Drug Interactions Other topical medications used concurrently Food Interactions No significant interactions |
Adverse Reactions Atopic dermatitis Contact dermatitis Pruritis Hypersensitivities including anaphylaxis |
Contraindications Hypersensitivity Caution: Avoid occlusive dressings to prevent systemic absorption |
Topical Anti-infectives for Burns
The greatest risk from minor burns is infection. Because a burn removes layers of skin, an open lesion forms, breaking the skin’s integrity and allowing bacteria and other organisms to enter the client’s body. Silver sulfadiazine and mafenide acetate are two topical anti-infectives used in the treatment and prevention of infection for localized second- and third-degree burns. As with sodium sulfacetamide, these medications are sulfa compounds that should not be administered to those with sulfa allergies. The nurse should take care to maintain a sterile environment when applying these medications to aid in preventing bacterial transfer to the client. To remain effective, burns should be completely covered with cream at all times to prevent bacterial colonization (DailyMed, Sulfamylon, 2023).
Table 40.13 lists common topical medications used in treating burns with typical routes and dosing for adult and pediatric clients.
Drug | Routes and Dosage Ranges |
---|---|
Mafenide acetate (Sulfamylon) |
Adults and children >2 months: Apply cream once or twice daily, to a thickness of approximately inch. |
Silver sulfadiazine (Silvadene) |
Adults and children >2 months: Apply cream once or twice daily, to a thickness of approximately inch. |
Adverse Effects and Contraindications
Adverse effects associated with topical medications for burns include hypersensitivities, pruritis, localized irritation, redness, and peeling. When covered with occlusive dressings, clients may experience systemic absorption, resulting in the likelihood of systemic effects. For this reason, occlusive dressings are contraindicated. Contraindications include hypersensitivities to drugs or their components.
Table 40.14 is a drug prototype table for common burn treatments featuring silver sulfadiazine. It lists drug class, mechanism of action, adult and pediatric dosage, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.
Drug Class Topical antibiotic Mechanism of Action Bactericidal; disrupts cell wall |
Drug Dosing Adults and children >2 months: Apply cream once or twice daily, to a thickness of approximately inch. |
Indications Second- and third-degree burns Therapeutic Effects Absence of infectious organisms in wound bed |
Drug Interactions Other topical medications used concurrently Cimetidine Food Interactions No significant interactions |
Adverse Reactions Hypersensitivities Necrosis Erythema multiforme Skin discoloration Burning sensation Rashes Interstitial nephritis Leucopenia |
Contraindications Hypersensitivity Sulfa allergy Pregnant clients approaching or at term Premature infants or newborn infants during the first 2 months of life |
Safety Alert
Silver Sulfadiazine
Silver sulfadiazine is widely used for burns with low risk of adverse effects. Overdose is uncommon, but systemic absorption can still occur. Care should be taken when applying the medication near mucosal or ocular areas or when it is used over a large body surface area.
(Source: Oaks & Cindass, 2023)
Nursing Implications
The nurse should do the following for clients who are using drugs for the treatment of burns:
- Conduct vigilant assessments for baseline, response to treatment, adverse effects, infection, and systemic absorption.
- Monitor creatinine for decreased renal function from possible effects of systemic absorption.
- Observe for hypersensitivity reactions during and after administration.
- Apply topical medications with gloves.
- Maintain aseptic technique when applying medications.
- Emphasize the importance of compliance with instructions and follow up with clients when necessary.
- Provide client teaching regarding the drug and when to call the health care provider. See below for client teaching guidelines.
Client Teaching Guidelines
The client using a topical medication for burns should:
- Take prescribed medications exactly as directed.
- Wash hands well before and after application.
- Report side effects such as skin redness, excessive dryness, or peeling to the primary provider.
- Report drainage, odor, temperature above 100.4°F, or other unusual symptoms to the primary provider.
- Cleanse skin thoroughly before applying medication.
- Avoid contact with eyes and mucous membranes.
The client using a topical medication for burns should not:
- Cover the medication with occlusive dressings.
FDA Black Box Warning
Pimecrolimus
Pimecrolimus cream has been associated with skin malignancies and lymphoma. Continuous long-term use should be avoided in any age group. Its use is not indicated for children less than 2 years of age.
Case Study
Read the following clinical scenario to answer the questions that follow.
Within the last year, Melissa Allen, a 27-year old patient, has gotten married, moved to a new city, and begun graduate school. Recently, she has noticed feeling a little more tired than usual and has experienced generalized joint pain.
History
Right ankle fracture
Seasonal sinusitis
Current Medications
Ibuprofen, 400 mg every 4 hours as needed
Yasmin birth control pill (drospirenone 3 mg/ethinyl estradiol 0.03 mg)
Vital Signs | Physical Examination | |
---|---|---|
Temperature: | 97.4°F |
|
Blood pressure: | 126/64 mm Hg | |
Heart rate: | 88 beats/min | |
Respiratory rate: | 14 breaths/min | |
Oxygen saturation: | 100% on room air | |
Pain: | 3/10 | |
Height: | 5'5" | |
Weight: | 144 lb |